This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Gordon M Keller: Innovator in Cell Replacement Therapy
Introduction
Gordon M Keller is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cell biology, particularly in the area of cell replacement therapy. His innovative work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Keller holds a patent for "Mesoderm and definitive endoderm cell populations." This invention provides cell populations that are enriched for mesendoderm and mesoderm, as well as cell populations that are enriched for endoderm. The cell populations of this invention are useful for generating cells for cell replacement therapy, showcasing Keller's commitment to advancing medical science.
Career Highlights
Gordon M Keller is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts research and develops innovative solutions in the field of regenerative medicine. His work is recognized for its potential to transform therapeutic approaches in treating various diseases.
Collaborations
Keller collaborates with esteemed colleagues, including Valerie Kouskoff and Atsushi Kubo. These partnerships enhance the research efforts and contribute to the advancement of knowledge in cell biology.
Conclusion
Gordon M Keller's contributions to the field of cell replacement therapy through his innovative patents and collaborations highlight his role as a leading inventor in medical research. His work continues to pave the way for future advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile